The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGamma Communications Regulatory News (GAMA)

Share Price Information for Gamma Communications (GAMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,460.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.274%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,460.00
GAMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Gamma Communications plc makes Dutch acquisition

2 Oct 2018 07:00

RNS Number : 6160C
Gamma Communications PLC
02 October 2018
 

RNS REACH

2 October 2018

Gamma Communications plc

 

Acquisition expands geographic profile

Drives further growth opportunities

 

Gamma Communications plc ("Gamma"), a leading, technology based provider of communications services to the UK business market, is pleased to announce the acquisition of DX Groep BV ("Dean One"). Dean One is a growing telecoms group based in the Netherlands.

 

Dean One is a business with many similar attributes to Gamma. It is largely a channel-led business, focused on products that Gamma has strong knowledge of and experience in. The market penetration and growth rates in sales of Cloud PBX in the Netherlands are similar to those in the UK, where Gamma has a track record in driving sustainable growth. 

 

Gamma management have known the Dean One business for a number of years. It has a very similar product set to Gamma, selling Cloud PBX, SIP trunks, data products and mobile to primarily SME businesses via a network of over 500 channel partners. It employs approximately 60 people. In the year ended 31 December 2017 revenue was c. €15.8 million and EBITDA was c. €0.8million.

 

The Board believes that, as part of Gamma, Dean One's growth can accelerate and that Dean One can act as a focal point through which Gamma can broaden its geographic footprint in the medium term. Gamma will also use the acquisition as an opportunity to take products which have been successful in the UK into new markets.

 

The impact on Gamma's results for 2018 is not material but the business is cash generative and the acquisition will enhance earnings immediately following completion. The acquisition is not considered a substantial transaction as defined in AIM Rule 12.

 

Financial terms

 

Consideration for the acquisition consists of an initial cash consideration paid on completion of €13.2m with a deferred contingent consideration of up to an additional €14.0m. The total maximum consideration (i.e. the initial and the deferred contigent payment) will be based on 7.5x the 2019 EBITDA of the acquired business. The consideration for the acquisition will be funded entirely from Gamma's existing cash resources.

 

Andrew Taylor, Chief Executive of Gamma, commented on the acquisition:

 

"We are really pleased to announce the acquisition of Dean One. It is an ideal way for us to expand into a new geography, opening up another growth opportunity for us. We have known the Dean One team for a number of years and see the business as a very good fit. We are really looking forward to working alongside the Dean One team as we continue to grow Gamma, leveraging our experience and resources, to capitalise on the opportunities ahead"

 

 

 

Klaas Bottema, co-Chief Executive of Dean One, commented:

 

"Gamma is the right home for Dean One, as we look to accelerate the success we have seen in the Netherlands. They have tremendous technical and market expertise, and a track record in building and managing the Channel. With their support, there is no doubt that we can grow more quickly and move into other markets which we don't currently serve. We know Gamma very well and believe that this is a positive development for all involved"

 

Gamma Communications plc

Andrew Taylor, Chief Executive Officer

Andrew Belshaw, Chief Financial Officer

Tel: +44 (0) 333 006 5972

 

 

Tulchan Communications LLP

James Macey White / Matt Low

Tel: +44 (0) 207 353 4200

 

 

Investec Bank plc (NOMAD & Broker)

Tel: +44 (0) 207 597 5970

Patrick Robb / Neil Coleman

Andrew Pinder / Sebastian Lawrence

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAUGGPCUUPRPGG
Date   Source Headline
1st Sep 20213:14 pmRNSTotal Voting Rights
5th Aug 20212:58 pmRNSTotal Voting Rights
23rd Jul 20217:00 amRNSDirectors disclosure update
14th Jul 20213:04 pmRNSTrading Statement
13th Jul 20217:00 amRNSTrading Statement
1st Jul 20213:41 pmRNSTotal Voting Rights
23rd Jun 20215:54 pmRNSExercise of Options
1st Jun 20212:43 pmRNSTotal Voting Rights
28th May 20212:47 pmRNSIssue of Equity
27th May 20215:24 pmRNSBlock Listing Application
21st May 202111:53 amRNSResult of AGM
20th May 20217:00 amRNSAGM Trading Update
12th May 20216:19 pmRNSBlock listing Interim Review
4th May 20216:13 pmRNSTotal Voting Rights
20th Apr 20213:00 pmRNSDirector/PDMR Shareholding
9th Apr 20215:47 pmRNSDirector/PDMR Shareholding
8th Apr 20215:26 pmRNSNotice of AGM
8th Apr 202112:05 pmRNSHolding(s) in Company
6th Apr 20217:00 amRNSTotal Voting Rights
1st Apr 20214:47 pmRNSDirector/PDMR Shareholding
1st Apr 20211:00 pmRNSHolding(s) in Company
1st Apr 202112:45 pmRNSHolding(s) in Company
30th Mar 20217:00 amRNSDirectorate Change
30th Mar 20217:00 amRNSResults of placing in Gamma Communications
29th Mar 20216:06 pmRNSIssue of Equity
29th Mar 20214:47 pmRNSProposed placing in Gamma Communications
24th Mar 20216:26 pmRNSHolding(s) in Company
23rd Mar 20217:02 amRNSAnnual Financial Report
23rd Mar 20217:00 amRNSDirectorate Change
19th Mar 202112:14 pmRNSHolding(s) in Company
3rd Mar 20217:00 amRNSAcquisition of Mission Labs Limited
1st Mar 20213:29 pmRNSTotal Voting Rights
12th Feb 20214:25 pmRNSHolding(s) in Company
3rd Feb 20212:49 pmRNSHolding(s) in Company
19th Jan 20214:50 pmRNSHolding(s) in Company
15th Jan 20215:17 pmRNSDirector/PDMR Shareholding
11th Jan 20217:00 amRNSTrading Statement
4th Jan 20216:08 pmRNSTotal Voting Rights
23rd Dec 20205:47 pmRNSDirector/PDMR Shareholding
17th Dec 202011:59 amRNSDirector/PDMR Shareholding
10th Dec 20206:08 pmRNSDirector/PDMR Shareholding
2nd Dec 20204:55 pmRNSDirector/PDMR Shareholding
1st Dec 20206:17 pmRNSTotal Voting Rights
1st Dec 20206:08 pmRNSDirector/PDMR Shareholding
16th Nov 20206:25 pmRNSBlock listing Interim Review
2nd Nov 20203:52 pmRNSTotal Voting Rights
30th Oct 20204:07 pmRNSHolding(s) in Company
22nd Oct 20205:43 pmRNSDirector/PDMR Shareholding
13th Oct 20203:39 pmRNSHolding(s) in Company
8th Oct 202011:27 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.